These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21775886)

  • 41. Pseudomonas keratitis associated with daily wear of silicone hydrogel contact lenses.
    Schornack MM; Faia LJ; Griepentrog GJ
    Eye Contact Lens; 2008 Mar; 34(2):124-8. PubMed ID: 18327051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery.
    Jensen MK; Fiscella RG
    Am J Health Syst Pharm; 2006 Sep; 63(17):1637-40. PubMed ID: 16914634
    [No Abstract]   [Full Text] [Related]  

  • 43. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Glidden DV; Ray KJ; Hong KC; Oldenburg CE; Lee SM; Zegans ME; McLeod SD; Lietman TM; Acharya NR;
    Arch Ophthalmol; 2012 Feb; 130(2):143-50. PubMed ID: 21987582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG; Mah FS; Yates KA; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.
    McClintic SM; Prajna NV; Srinivasan M; Mascarenhas J; Lalitha P; Rajaraman R; Oldenburg CE; O'Brien KS; Ray KJ; Acharya NR; Lietman TM; Keenan JD
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2935-40. PubMed ID: 24618327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrastromal injection of antibiotic agent in the management of recalcitrant bacterial keratitis.
    Liang SY; Lee GA
    J Cataract Refract Surg; 2011 May; 37(5):960-2. PubMed ID: 21511159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India.
    Oldenburg CE; Lalitha P; Srinivasan M; Rajaraman R; Ravindran M; Mascarenhas J; Borkar DS; Ray KJ; Zegans ME; McLeod SD; Porco TC; Lietman TM; Acharya NR
    Ophthalmic Epidemiol; 2013 Jun; 20(3):155-8. PubMed ID: 23662986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment.
    Miller WL; Giannoni AG; Perrigin J
    Cont Lens Anterior Eye; 2008 Aug; 31(4):201-6. PubMed ID: 18595770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isolation of Kingella denitrificans from a corneal ulcer.
    Kim YH; Panday V; Reilly C
    Cornea; 2011 Apr; 30(4):472-3. PubMed ID: 21099406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fungal keratitis responsive to moxifloxacin monotherapy.
    Matoba AY
    Cornea; 2012 Oct; 31(10):1206-9. PubMed ID: 22673848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.
    Stroman DW; Dajcs JJ; Cupp GA; Schlech BA
    Surv Ophthalmol; 2005 Nov; 50 Suppl 1():S16-31. PubMed ID: 16257308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Community practice patterns for bacterial corneal ulcer evaluation and treatment.
    Park J; Lee KM; Zhou H; Rabin M; Jwo K; Burton WB; Gritz DC
    Eye Contact Lens; 2015 Jan; 41(1):12-8. PubMed ID: 25536529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bilateral corneal ulceration in keratoconus.
    Shih CY; Bosjolie A; Qiao M; Udell IJ
    Ophthalmology; 2012 Oct; 119(10):2192-2192.e3. PubMed ID: 23034295
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microbial keratitis in a case of lamellar ichthyosis.
    Chaurasia S; Das S; Ramamurthy B
    Int Ophthalmol; 2008 Oct; 28(5):367-8. PubMed ID: 17828596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late-onset laser in situ keratomileusis-related corneal ulcer--a case series.
    Varssano D; Waisbourd M; Berkner L; Regenbogen M; Hazarbassanov R; Michaeli A
    Cornea; 2009 Jun; 28(5):586-8. PubMed ID: 19421033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microbial keratitis secondary to infection with Citrobacter koseri.
    Goold LA; Warrier SK; Wittles NK; Nathan F
    Cornea; 2010 Apr; 29(4):479. PubMed ID: 20164753
    [No Abstract]   [Full Text] [Related]  

  • 59. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.
    Lalitha P; Srinivasan M; Manikandan P; Bharathi MJ; Rajaraman R; Ravindran M; Cevallos V; Oldenburg CE; Ray KJ; Toutain-Kidd CM; Glidden DV; Zegans ME; McLeod SD; Acharya NR; Lietman TM
    Clin Infect Dis; 2012 May; 54(10):1381-7. PubMed ID: 22447793
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas corneal ulcer associated with disposable soft contact lenses.
    Kent HD; Sanders RJ; Arentsen JJ; Cohen EJ; Laibson PR
    CLAO J; 1989; 15(4):264-5. PubMed ID: 2805313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.